{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:37:17Z","timestamp":1787071037252,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Corticosteroids are the most common agents used in the treatment of alopecia areata (AA), however, their long-term use is associated with severe side effects. Therefore, other immunosuppressive agents have been tried and azathioprine appears to be an effective and promising alternative.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The main objective of this study was to compare the efficacy of 300 mg once weekly azathioprine pulse (WAP) and 5 mg betamethasone on 2 consecutive days every week in the management of AA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In this open-label, randomized comparative study, 50 patients of AA with &gt;10% scalp area involvement were treated with either 300 mg WAP or 5 mg betamethasone on 2 consecutive days every week for 4 months or till complete scalp hair regrowth and followed up for next 5 months. Primary efficacy parameters were average percentage scalp hair regrowth and change in average Severity of Alopecia Tool (SALT) score at 4 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twenty patients in WAP group and 21 patients in betamethasone group completed the study. The median percent scalp hair regrowth and the median change in SALT score was 44.52 and 9.5 in WAP group compared to 71.43 and 14 in betamethasone group at 4-month, respectively, which were statistically similar in two groups, however, side effects were significantly higher in betamethasone group. On further follow-up at 9 months, 10 (50%) patients in WAP group and 13 (62%) patients in betamethasone group achieved complete hair regrowth. Lack of control group was a limitation of our study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>WAP and betamethasone therapy, both appear to be effective in the treatment of AA. However, betamethasone caused several side effects; therefore, WAP can be used as a better alternative to corticosteroids in AA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_481_16","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T04:14:30Z","timestamp":1562300070000},"page":"292-298","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Weekly Azathioprine Pulse versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate-to-Severe Alopecia Areata"],"prefix":"10.4103","volume":"64","author":[{"given":"Prashant","family":"Gupta","sequence":"first","affiliation":[{"name":"From the Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushal K","family":"Verma","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujay","family":"Khandpur","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu","family":"Bhari","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250921","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2340\/0001555572373375","article-title":"The genetic risk for alopecia areata in first degree relatives of severely affected patients. An estimate","volume":"72","author":"van der Steen","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"R2-20250921","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1365-4632.2010.04576.x","article-title":"Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study","volume":"49","author":"Farshi","year":"2010","journal-title":"Int J Dermatol"},{"key":"R3-20250921","first-page":"34","article-title":"Lichen planus treated with betamethasone oral mini-pulse therapy","volume":"66","author":"Verma","year":"2000","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R4-20250921","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-4362.1993.tb02754.x","article-title":"Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease","volume":"32","author":"Pasricha","year":"1993","journal-title":"Int J Dermatol"},{"key":"R5-20250921","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/000155500750012487","article-title":"Azathioprine as a corticosteroid-sparing agent for the treatment of dermatitis caused by the weed Parthenium","volume":"80","author":"Verma","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"R6-20250921","first-page":"30","article-title":"Azathioprine as a corticosteroid-sparing agent in air-borne contact dermatitis","volume":"62","author":"Verma","year":"1996","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R7-20250921","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/0378-6323.19713","article-title":"Parthenium dermatitis treated with azathioprine weekly pulse doses","volume":"72","author":"Verma","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R8-20250921","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/0378-6323.154788","article-title":"Weekly azathioprine pulse versus daily azathioprine in the treatment of Parthenium dermatitis: A non-inferiority randomized controlled study","volume":"81","author":"Verma","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R9-20250921","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-4362.1996.tb03281.x","article-title":"Pulsed administration of corticosteroids in the treatment of alopecia areata","volume":"35","author":"Sharma","year":"1996","journal-title":"Int J Dermatol"},{"key":"R10-20250921","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaad.2004.10.873","article-title":"Placebo-controlled oral pulse prednisolone therapy in alopecia areata","volume":"52","author":"Kar","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R11-20250921","first-page":"350","article-title":"Extensive alopecia areata treated with betamethasone oral mini-pulse therapy: An open uncontrolled study","volume":"70","author":"Khaitan","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R12-20250921","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0378-6323.148608","article-title":"Intravenous methylprednisolone pulse therapy in severe alopecia areata","volume":"81","author":"Senila","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R13-20250921","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000107626","article-title":"Pulse corticosteroid therapy for alopecia areata: Study of 139 patients","volume":"215","author":"Nakajima","year":"2007","journal-title":"Dermatology"},{"key":"R14-20250921","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0190-9622(98)70009-X","article-title":"Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients","volume":"39","author":"Friedli","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"R15-20250921","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000051642","article-title":"High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata","volume":"202","author":"Seiter","year":"2001","journal-title":"Dermatology"},{"key":"R16-20250921","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000341523","article-title":"Pulse corticosteroid therapy for alopecia areata: Long-term outcome after 10 years","volume":"225","author":"Staumont-Sall\u00e9","year":"2012","journal-title":"Dermatology"},{"key":"R17-20250921","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1346-8138.1999.tb02049.x","article-title":"Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata","volume":"26","author":"Sharma","year":"1999","journal-title":"J Dermatol"},{"key":"R18-20250921","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/dth.12255","article-title":"Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: A long-term follow-up study","volume":"28","author":"Lalosevic","year":"2015","journal-title":"Dermatol Ther"},{"key":"R19-20250921","doi-asserted-by":"crossref","first-page":"676","DOI":"10.5021\/ad.2015.27.6.676","article-title":"Comparison of high-dose corticosteroid pulse therapy and combination therapy using oral cyclosporine with low-dose corticosteroid in severe alopecia areata","volume":"27","author":"Yeo","year":"2015","journal-title":"Ann Dermatol"},{"key":"R20-20250921","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/1346-8138.13388","article-title":"Multiple courses of pulse corticosteroid therapy for alopecia areata","volume":"43","author":"Yoshimasu","year":"2016","journal-title":"J Dermatol"},{"key":"R21-20250921","doi-asserted-by":"crossref","first-page":"569","DOI":"10.5021\/ad.2016.28.5.569","article-title":"A comparative study of oral cyclosporine and betamethasone minipulse therapy in the treatment of alopecia areata","volume":"28","author":"Jang","year":"2016","journal-title":"Ann Dermatol"},{"key":"R22-20250921","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/1346-8138.14535","article-title":"Chronological clinicopathological characterization of rapidly progressive alopecia areata resistant to multiple i.v. corticosteroid pulse therapies: An implication for improving the efficacy","volume":"45","author":"Fukuyama","year":"2018","journal-title":"J Dermatol"},{"key":"R23-20250921","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jaad.2015.09.045","article-title":"A systematic review of pulse steroid therapy for alopecia areata","volume":"74","author":"Shreberk-Hassidim","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R24-20250921","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","article-title":"Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata","volume":"128","author":"Olsen","year":"1992","journal-title":"Arch Dermatol"},{"key":"R25-20250921","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2005.09.010","article-title":"The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis","volume":"55","author":"Joly","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R26-20250921","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/09546630701846095","article-title":"Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata","volume":"19","author":"Kim","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"R27-20250921","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00403-009-0936-8","article-title":"Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata","volume":"301","author":"Ito","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"R28-20250921","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2133.2011.10575.x","article-title":"British Association of Dermatologists\u2019 guidelines for the safe and effective prescribing of azathioprine 2011","volume":"165","author":"Meggitt","year":"2011","journal-title":"Br J Dermatol"},{"key":"R29-20250921","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1155\/2005\/470863","article-title":"Thiopurine methyltransferase enzyme activity determination before treatment of inflammatory bowel disease with azathioprine: Effect on cost and adverse events","volume":"19","author":"Sayani","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"R30-20250921","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MPG.0b013e3182844705","article-title":"Role of thiopurine metabolite testing and thiopurine methyltransferase determination in pediatric IBD","volume":"56","author":"Benkov","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R31-20250921","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00008571-199902000-00006","article-title":"The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations","volume":"9","author":"Collie-Duguid","year":"1999","journal-title":"Pharmacogenetics"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00076423-201964040-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:36Z","timestamp":1787067636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00076423-201964040-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_481_16","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"2018-08-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}